Overview

Bilateral Transversus Abdominis Plane Block Versus Atracurium During Laparoscopic Gynecology Procedures.

Status:
Completed
Trial end date:
2015-10-31
Target enrollment:
0
Participant gender:
All
Summary
A monocentric, prospective, randomized controlled trial, including patients proposed for a laparoscopic gynecologic surgery comparing the muscular relaxing effect of a bilateral ultrasound-guided Transversus Abdominis Plane block to usual neuromuscular blockade agent (Atracurium)
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Tunis El Manar
Treatments:
Atracurium
Neuromuscular Blocking Agents
Criteria
Inclusion Criteria:

- American Association of anesthesiologists' class I to III (ASA I to ASA III)

- undergoing laparoscopic gynecologic procedures

Non inclusion Criteria:

- patients' refusal to be part of the study

- ASA IV and higher

- known allergic history to Propofol or any of its components (eggs, soya and beans,
etc.), suxamethonium, Fentanyl or Atracurium.

- Patients who presents any regional anesthesia contraindication as clotting disorders,
injection site infection and allergy to local anesthetics

- Psychiatric and neurologic disorders and the inability to understand pain scores and
the study protocol

Exclusion Criteria:

- unsuccessful TAP block

- Observed anesthesia or surgical incident which requires the end of the ongoing
procedure or the conversion to laparotomy